IRIS

Dibutyl phthalate (DBP)

CASRN 84-74-2

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (11 pp, 107 K) Last Updated: 01/31/1987

System RfD (mg/kg-day) Basis PoD Composite UF Confidence
Other 1 x 10-1 Increased mortality NOAEL : 1.25 x 102
mg/kg-day
1000 Low

 


Reference Concentration for Inhalation Exposure (RfC) (PDF) (11 pp, 107 K) Last Updated: 10/01/1990
Information reviewed but value not estimated.

 

Cancer Assessment

Weight of Evidence for Cancer (PDF) (11 pp, 107 K) Last Updated: 09/07/1988

WOE Characterization Framework for WOE Characterization
D (Not classifiable as to human carcinogenicity) Guidelines for Carcinogen Risk Assessment (U.S. EPA, 1986)
Basis:
  • Pertinent data regarding carcinogenicity was not located in the available literature.
  • This may be a synopsis of the full weight-of-evidence narrative.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (11 pp, 107 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (11 pp, 107 K)

Not assessed under the IRIS Program.


Note: The dibutyl phthalate (dbp) (re)assessment has been discontinued. A new/updated assessment will not be added to the IRIS database at this time.

Assessment Manager(s): James Avery (avery.james@epa.gov)

Step Assessment Materials Released to the Public Release Date Public Meeting Date
1 Preliminary Assessment Materials 01/2015 02/2015
  Discontinued 12/2018  

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.